ND

Neelam Devi

Active Director Director DIN 09542866
DIN 09542866 First appointment Mar 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2022
Shareholding value •••• Premium profile

About Neelam Devi

Data last updated:

Neelam Devi is a Director at Hypatho Lab Private Limited (since 2022). The company operates in Healthcare. Hypatho Lab Private Limited reported revenue of ₹20.22 Cr (FY 2025).

DIN 09542866
Primary Designation Director
Industry Healthcare
First Appointment 22 Mar 2022
Oldest Company Age 4 yrs
Largest company Hypatho Lab Private Limited · ₹20.22 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hypatho Lab Private Limited U85300DL2022PTC395312
Director22 Mar 20222022₹20.22 Cr (FY 2025)Active

Board colleagues of Neelam Devi

NameDINCompanyDesignation
Vivek Kumar Yadav09542865Hypatho Lab Private LimitedDirector

Directorship timeline

Open interactive timeline →
Hypatho Lab Private Limited
Premium access

Shareholding and investment profile for Neelam Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neelam Devi

Neelam Devi currently holds 1 directorship: Hypatho Lab Private Limited (Director, since 22 Mar 2022, revenue ₹20.22 Cr (FY 2025)).

Neelam Devi was first appointed on 22 Mar 2022 as Director at Hypatho Lab Private Limited.

The current boards of Neelam Devi's companies include Vivek Kumar Yadav (Hypatho Lab Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available